See How Many Clients You're Missing Each Month
Simply enter your business email & Topline AI Agent will show you.
Thomas Thaler (Phd)
Investment Advisor Medical Technology at HBM Partners AG
PhD holder with expertise in venture capital, private equity, and investments in medical technology.
- Claim this Profile
Location
Zug, Zug, Switzerland, CH
Languages
-
German -
-
English -
-
French -
Skills
- Venture Capital
- Private Equity
- Investments
- Valuation
- Mergers And Acquisitions
- Show all
Bio
Generated by
Topline AI
Thomas Thaler is a seasoned expert in venture capital, private equity, and investments with a strong background in medical technology. He has held various leadership positions, including Investment Advisor at HBM Partners AG and Board Member at several companies. Thaler holds a PhD in Cell/Cellular and Molecular Biology from ETH Zürich.
Experience
-
HBM Partners AG
-
Zug, Switzerland
-
Investment Advisor Medical Technology
-
Feb 2006 - Present
-
Zug, Switzerland
-
-
-
Shape Memory Medical Inc.
-
Santa Clara, CA, USA
-
Board Member
-
Jul 2017 - Present
-
Santa Clara, CA, USA
-
-
-
Vascular Dynamics
-
Mountain View, CA, USA
-
Board Member
-
Oct 2014 - Present
-
Mountain View, CA, USA
-
-
-
Valcare
-
Irvine, CA, USA
-
Board Member
-
Jun 2012 - Present
-
Irvine, CA, USA
-
-
-
Cardialen, Inc.
-
Greater Minneapolis-St. Paul Area
-
Board Member
-
Jul 2018 - Mar 2023
-
Greater Minneapolis-St. Paul Area
-
-
-
MicroOptx
-
Greater Minneapolis-St. Paul Area
-
Board Member
-
Aug 2019 - Feb 2023
-
Greater Minneapolis-St. Paul Area
-
-
-
Interventional Spine
-
Irvine, CA, USA
-
Board Member
-
Apr 2007 - Dec 2019
-
Irvine, CA, USA
-
-
-
Amphora Medical, Inc.
-
Minneapolis, MN, USA
-
Board Member
-
Jul 2017 - May 2019
-
Minneapolis, MN, USA
-
-
-
MiCardia
-
Irvine, CA, USA
-
Board Member
-
Apr 2007 - Mar 2018
-
Irvine, CA, USA
-
-
-
Tensys Medical
-
San Diego, CA, USA
-
Chairman of the Board
-
Jan 2010 - Dec 2017
-
San Diego, CA, USA
Tensys Medical’s assets were acquired by a Chinese Company.
-
-
-
Ellipse Technologies
-
Irvine, CA, USA
-
Board Member
-
Jun 2011 - Feb 2016
-
Irvine, CA, USA
Ellipse Technologies was acquired by Nuvasive (February 2016) for $380m cash upfront and $30m milestone-related payments
-
-
-
Precimed
-
Orvine, Switzerland
-
Board Member
-
Feb 2007 - Jan 2008
-
Orvine, Switzerland
Precimed was acquired by Greatbatch
-
-
-
-
Medtech / HC analyst, Senior Vice President
-
2000 - 2006
-
-
-
-
Director Clinical and Regulatory Affairs
-
Jan 1997 - May 2000
-
-
-
-
Head of Applied Research
-
1992 - 1997
-
-
-
-
Head Development and Process Engineering; Deputy CEO
-
1987 - 1992
-
-
-
Swiss Federal Institute of Technology (ETH), Inst. for Cell Biology
-
Zürich Area, Switzerland
-
Post-doctoral Research Associate
-
1985 - 1987
-
Zürich Area, Switzerland
Structural and Functional Investigations on Membrane Proteins.
-
-
Education
-
1985 - 1987ETH Zürich
Master's Degree in Management, Technology and Economics;, (Finance, Accounting and Business/Management) -
1982 - 1985
ETH Zürich
Doctor of Philosophy (Ph.D.), Cell/Cellular and Molecular Biology -
1977 - 1982
ETH Zürich
Dipl. Natw. ETH, Natural Sciences (Biochemistry, Cell Biology, Microbiology) -
1981 - 1981
University of London, King's College
Natural Sciences
Suggested Services
This profile is unclaimed. These are suggested service rates with 0% commision upon successful connection
Industry Focus. “Investment Management”
Looking to Create a Custom Project?
Get Started
Need a custom project? We'll create a solution designed specifically for your project.
References
Social Profiles
Community
You need to have a working account to view this content.
Click here to join now
